Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Operations (2020 - 2025)

Historic Cash from Operations for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$2.0 million.

  • iSpecimen's Cash from Operations fell 8858.37% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 5868.7%. This contributed to the annual value of -$8.3 million for FY2024, which is 4229.26% down from last year.
  • As of Q3 2025, iSpecimen's Cash from Operations stood at -$2.0 million, which was down 8858.37% from -$192234.0 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Cash from Operations peaked at $345141.0 during Q4 2023, and registered a low of -$6.1 million during Q3 2021.
  • Its 5-year average for Cash from Operations is -$1.8 million, with a median of -$1.6 million in 2023.
  • As far as peak fluctuations go, iSpecimen's Cash from Operations tumbled by 525335.47% in 2021, and later skyrocketed by 26645.01% in 2023.
  • Over the past 5 years, iSpecimen's Cash from Operations (Quarter) stood at -$1.3 million in 2021, then skyrocketed by 84.29% to -$207354.0 in 2022, then surged by 266.45% to $345141.0 in 2023, then plummeted by 1135.14% to -$3.6 million in 2024, then skyrocketed by 43.02% to -$2.0 million in 2025.
  • Its Cash from Operations was -$2.0 million in Q3 2025, compared to -$192234.0 in Q2 2025 and -$1.1 million in Q1 2025.